ViewMind Inc.

ViewMind Inc. is honored to be part of StartUp Health. We're pleased to share this article about our non-invasive functional brain health meter. #technology #innovation #impact #alzheimers #brainhealth

We’re honored ViewMind Inc. has been recognized as CNS Summit 2024 Poster Winner.? Our poster, “Motor Disabilities Linked to Increased Abnormal Eye Movements in Multiple Sclerosis: Findings from an Eye-Tracking Study”, was showcased on November 12. This recognition reinforces the potential of digital biomarkers in advancing non-invasive diagnostics and monitoring for neurological conditions. Thank you to the CNS Summit team for the opportunity to share our work and to everyone who connected with our CEO & Co-founder, Mark Edwards, and CCO, Abhi Vase, during the event. We look forward to continuing the conversation about innovative solutions in brain health diagnostics. Let’s keep driving progress together. #CNSSummit2024 #BrainHealth #DigitalHealth #Innovation #HealthTech #DigitalBiomarkers

We are happy to announce that ViewMind Inc. has been named a finalist for the Accelerate UK 2024 competition! This selection places us among the top 20 startups and scale-ups out of 360 companies. The program helps to accelerate access to the UK’s health ecosystem. Accelerate UK 2024 offers an invaluable opportunity for mentorship, industry insight, and connections. For companies like ViewMind, this program strengthens our mission to drive advancements in brain health assessments with cutting-edge ocular phenotyping technology. A big congratulations to the fellow finalists. #AccelerateUK2024 #InnovationEcosystem #InwardInvestment #Entrepreneurship #HealthTech #DigitalBiomarkers #ViewMind #BrainHealth #StartupGrowth #GlobalExpansion

From November 10-13 at CNS Summit, ViewMind Inc. will be showcasing innovative research in digital biomarkers, focusing on how eye movement behaviors correlate with physical and cognitive assessments in patients with Multiple Sclerosis (MS). We’re excited to present the poster #15:?? “Motor Disabilities Linked to Increased Abnormal Eye Movements in Multiple Sclerosis: Findings from an Eye-Tracking Study”? on Tuesday, November 12th at 5:00pm. Our CEO & Co-founder, Mark Edwards, and CCO Abhi Vase, will be on-site and would love to connect with healthcare leaders in the space. #CNSSummit2024 #ViewMind #BrainHealth #DigitalHealth #Innovation #MultipleSclerosis #HealthTech #InvestInHealth #DigitalBiomarkers #HealthcareTransformation #EncoreBostonHarbor

It was great to be at CTAD 2024 in Madrid presenting important findings that showcase ViewMind Inc.’s? technology’s impact on Alzheimer’s diagnostics: ? LP052: Exploring the Association between blood-based biomarkers and cognitive-related oculomotor behaviors in asymptomatic carriers of the autosomal dominant mutation E280A-PSEN1? ?LP086:? Associations between central and peripheral biomarkers for Alzheimer’s disease in community-dwelling older adults at risk of dementia. ?LP095: Psychometric Validity of Neurocognitive Biomarkers from ViewMind Thank you to everyone who stopped by to discuss these advances. We’re excited to keep pushing the boundaries in cognitive health and collaborate with experts who share our commitment to innovation in Alzheimer’s research. If you’d like to learn more about our findings, feel free to reach out! #CTAD2024 #AlzheimersResearch #CognitiveHealth #DigitalHealth #Neurodegeneration #ViewMind #Innovation CTAD Clinical Trials on Alzheimer's Disease

ViewMind Inc. is excited to share that the Mayo Clinic has presented results today at TCT2024, the world’s leading interventional cardiology research and educational conference, showcasing cognitive assessments powered by ViewMind’s technology. The multi-site study focused on evaluating cognitive recovery following a Left Atrial Appendage Occlusion (LAAO) procedure, comparing two types of anesthesia to monitor each patient’s cognitive recovery journey. Using ViewMind's advanced cognitive assessment solutions, the study tracked patients longitudinally, providing critical insights into post-operative brain health and recovery. We’re proud to be at the forefront of research by pioneering advanced technology to assess and detect subtle changes in functional brain health longitudinally, and that can positively impact patient outcomes in interventional cardiology. #TCT2024 #MayoClinic #InterventionalCardiology #HealthTech #Innovation #CognitiveHealth #TranscatheterCardiovascularTherapeutics Mark Edwards Danilo Verge Matias Shulz gerardo fernandez

It’s a pleasure to announce that ViewMind Inc. will be attending the Clinical Trials for Alzheimer’s Disease (CTAD) 2024 conference in Madrid from October 29 to November 1. We’re excited to present recent findings that highlight the potential of our technology in Alzheimer’s diagnostics: ? Significant correlations between ViewMind assessments and blood-based biomarkers of inflammation in asymptomatic early-onset familial AD patients; ? Correlation between ViewMind assessments and EEG measures of frontal lobe activity; ? Initial validation data correlating ViewMind’s assessments with the ACE-R test in a large sample of older adults, with and without cognitive impairment. If you’re attending CTAD, let’s connect to discuss how our cognitive health tools are supporting early detection and precision in Alzheimer’s research. #CTAD2024 #AlzheimersResearch #CognitiveHealth #DigitalHealth #Neurodegeneration #ViewMind

As HLTH 2024 wraps up, we want to take a moment to express our gratitude for the incredible opportunities this event has provided. It was an honor to be named one of the finalists by the Digital Health Hub Foundation at the Digital Health Awards. We’re honored to be recognized for our work in advancing brain health through innovative technology. A big thank you to all the industry leaders, colleagues, and partners we connected with throughout the event. These conversations and collaborations will undoubtedly drive us forward as we continue to innovate in digital health and cognitive health. If you’re interested in learning more about ViewMind Inc. and our cutting-edge solutions, don’t hesitate to reach out. We’re excited about what’s next! #HLTH2024 #DigitalHealth #BrainHealth #HealthcareInnovation #AI #Technology #CognitiveHealth #ViewMind HLTH Inc. The Digital Health Hub Foundation - Digital Health Awards

We're excited to be heading to HLTH 2024 in Las Vegas next week! Looking forward to connecting with industry colleagues and exploring the latest advancements in brain health, mental health, and technology, where innovators and leaders in healthcare gather to discuss the future of digital health. If you're also attending HLTH 2024 and would like to connect or learn more about ViewMind Inc. and our technology, don’t hesitate to reach out. #HLTH2024 #DigitalHealth #BrainHealth #HealthcareInnovation #AI #Technology #CognitiveHealth #ViewMind HLTH Foundation Mark Edwards

ViewMind Inc.?was recently featured on an episode of?Advancements, which aired on Bloomberg. The segment showcases our innovative approach to cognitive health through cutting-edge technology. Check out the video to learn more! #Bloomberg #Advancements #ViewMind #HealthTech #BrainHealth #HealthcareInnovation #DigitalHealth #CognitiveHealth #Technology #Innovation #Healthcare #PrecisionMedicine #Health #Brain